Cargando…
Metalloproteinase Inhibitors: Status and Scope from Marine Organisms
Marine environment has been the source of diverse life forms that produce different biologically active compounds. Marine organisms are consistently contributing with unparalleled bioactive compounds that have profound applications in nutraceuticals, cosmeceuticals, and pharmaceuticals. In this proc...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004377/ https://www.ncbi.nlm.nih.gov/pubmed/21197102 http://dx.doi.org/10.1155/2010/845975 |
_version_ | 1782193970970886144 |
---|---|
author | Thomas, Noel Vinay Kim, Se-Kwon |
author_facet | Thomas, Noel Vinay Kim, Se-Kwon |
author_sort | Thomas, Noel Vinay |
collection | PubMed |
description | Marine environment has been the source of diverse life forms that produce different biologically active compounds. Marine organisms are consistently contributing with unparalleled bioactive compounds that have profound applications in nutraceuticals, cosmeceuticals, and pharmaceuticals. In this process, screening of natural products from marine organisms that could potentially inhibit the expression of metalloproteinases has gained a huge popularity, which became a hot field of research in life sciences. Metalloproteinases, especially, matrix metalloproteinases (MMPs) are a class of structurally similar enzymes that contribute to the extracellular matrix degradation and play major role in normal and pathological tissue remodeling. Imbalance in the expression of MMPs leads to severe pathological condition that could initiate cardiac, cartilage, and cancer-related diseases. Three decades of endeavor for designing potent matrix metalloproteinase inhibitory substances (MMPIs) with many not making upto final clinical trials seek new resources for devising MMPIs. Umpteen number of medicinally valuable compounds being reported from marine organisms, which encourage current researchers to screen potent MMPIs from marine organisms. In this paper, we have made an attempt to report the metalloproteinase inhibiting substances from various marine organisms. |
format | Text |
id | pubmed-3004377 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-30043772010-12-30 Metalloproteinase Inhibitors: Status and Scope from Marine Organisms Thomas, Noel Vinay Kim, Se-Kwon Biochem Res Int Review Article Marine environment has been the source of diverse life forms that produce different biologically active compounds. Marine organisms are consistently contributing with unparalleled bioactive compounds that have profound applications in nutraceuticals, cosmeceuticals, and pharmaceuticals. In this process, screening of natural products from marine organisms that could potentially inhibit the expression of metalloproteinases has gained a huge popularity, which became a hot field of research in life sciences. Metalloproteinases, especially, matrix metalloproteinases (MMPs) are a class of structurally similar enzymes that contribute to the extracellular matrix degradation and play major role in normal and pathological tissue remodeling. Imbalance in the expression of MMPs leads to severe pathological condition that could initiate cardiac, cartilage, and cancer-related diseases. Three decades of endeavor for designing potent matrix metalloproteinase inhibitory substances (MMPIs) with many not making upto final clinical trials seek new resources for devising MMPIs. Umpteen number of medicinally valuable compounds being reported from marine organisms, which encourage current researchers to screen potent MMPIs from marine organisms. In this paper, we have made an attempt to report the metalloproteinase inhibiting substances from various marine organisms. Hindawi Publishing Corporation 2010 2010-12-09 /pmc/articles/PMC3004377/ /pubmed/21197102 http://dx.doi.org/10.1155/2010/845975 Text en Copyright © 2010 N. V. Thomas and S.-K. Kim. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Thomas, Noel Vinay Kim, Se-Kwon Metalloproteinase Inhibitors: Status and Scope from Marine Organisms |
title | Metalloproteinase Inhibitors: Status and Scope from Marine Organisms |
title_full | Metalloproteinase Inhibitors: Status and Scope from Marine Organisms |
title_fullStr | Metalloproteinase Inhibitors: Status and Scope from Marine Organisms |
title_full_unstemmed | Metalloproteinase Inhibitors: Status and Scope from Marine Organisms |
title_short | Metalloproteinase Inhibitors: Status and Scope from Marine Organisms |
title_sort | metalloproteinase inhibitors: status and scope from marine organisms |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004377/ https://www.ncbi.nlm.nih.gov/pubmed/21197102 http://dx.doi.org/10.1155/2010/845975 |
work_keys_str_mv | AT thomasnoelvinay metalloproteinaseinhibitorsstatusandscopefrommarineorganisms AT kimsekwon metalloproteinaseinhibitorsstatusandscopefrommarineorganisms |